Evidence map›Paper›PMID 18374328›Full record

ReviewEuropean journal of pharmacology2008

The substrates of memory: defects, treatments, and enhancement.

Gary Lynch, Christopher S Rex, Lulu Y Chen, Christine M Gall

Open access · greenAbstract readReview
In one paragraph

Review in European journal of pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 102 citations in OpenAlex.

  1. Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Ras Inhibitor Lonafarnib Rescues Structural and Functional Impairments of Synapses of AβThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  7. Article
  8. Review
  9. Evaluation of a TrkB agonist on spatial and motor learning in theLearning & memory (Cold Spring Harbor, N.Y.) · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. FK506-Binding Protein 12.6/1b, a Negative Regulator of [CaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gary LynchDepartment of Psychiatry and Human Behavior, University of California, Irvine CA, United States.
Christopher S Rex
Lulu Y Chen
Christine M Gall
University of California, Irvine · US

Funding

The Spine Cytoskeleton and Memory DisordersP01NS045260 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GALL, CHRISTINE M · 2003 to 2015
$14.4M
Training in the Neurobiology of Aging and Alzheimers DiseaseT32AG000096 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI VIVEK SWARUP, Craig E Stark · 1985 to 2026
$9.6M
NEUROBEHAVIOR, NEUROENDOCRINOLOGY, AND GENETICS OF ADT32AG000258 · NIA · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 1999 to 2013
$4.7M
INTEGRIN REGULATION AND FUNCTIONS IN ADULT BRAINR01NS037799 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GALL, CHRISTINE M · 1998 to 2007
$1.6M
Integrins and LTP consolidationR01NS051823 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LYNCH, GARY S · 2005 to 2008
$1.0M
CYTOSOLIC CALCIUM MODULATION OF THE ACTION POTENTIALZ01AG000258 · NIA · NATIONAL INSTITUTE ON AGING · PI LAKATTA, EDWARD · 1990 to 2008
$270k
Intramural NIH HHS Z01 AG000258NIA NIH HHS T32 AG000096NIA NIH HHS T32 AG000258NINDS NIH HHS NS045260NINDS NIH HHS NS051823NINDS NIH HHS NS37799NINDS NIH HHS P01 NS045260NINDS NIH HHS R01 NS037799NINDS NIH HHS R01 NS051823
6 · The paper itself

Abstract

Recent work has added strong support to the long-standing hypothesis that the stabilization of both long-term potentiation and memory requires rapid reorganization of the spine actin cytoskeleton. This development has led to new insights into the origins of cognitive disorders, and raised the possibility that a diverse array of memory problems, including those associated with diabetes, reflect disturbances to various components of the same mechanism. In accord with this argument, impairments to long-term potentiation in mouse models of Huntington's disease and in middle-aged rats have both been linked to problems with modulatory factors that control actin polymerization in spine heads. Complementary to the common mechanism hypothesis is the idea of a single treatment for addressing seemingly unrelated memory diseases. First tests of the point were positive: Brain-Derived Neurotrophic Factor (BDNF), a potent activator of actin signaling cascades in adult spines, rescued potentiation in Huntington's disease mutant mice, middle-aged rats, and a mouse model of Fragile-X syndrome. A similar reversal of impairments to long-term potentiation was obtained in middle-aged rats by up-regulating BDNF production with brief exposures to ampakines, a class of drugs that positively modulate AMPA-type glutamate receptors. Work now in progress will test if chronic elevation of BDNF enhances memory in normal animals.

Indexed as

Long-Term PotentiationMemory DisordersActinsAgingAnimalsBrainBrain-Derived Neurotrophic FactorCytoskeletonDendritic SpinesFragile X SyndromeHumansHuntington DiseaseLearningMemoryNootropic AgentsSynapsesActinsBrain-Derived Neurotrophic FactorNootropic Agents

Identifiers

PMID18374328
PMCPMC2427007
OpenAlexW2079463522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.